14 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
26
Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists.
James Black Foundation
23
Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity.
Bristol Myers Squibb
3
Side chain cyclization based on serine residues: synthesis, structure, and activity of a novel cyclic analogue of the parathyroid hormone fragment 1-11.
University of Padova
9
Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe.
Pharmaceutical Research Institute
15
Lead optimization of pyrido[2,3-d][1]benzazepin-6-one derivatives leading to the discovery of a potent, selective, and orally available human parathyroid hormone receptor 1 (hPTHR1) antagonist (DS69910557).
Daiichi Sankyo
13
Discovery of novel, potent, and orally bioavailable pyrido[2,3-d][1]benzazepin-6-one antagonists for parathyroid hormone receptor 1.
Daiichi Sankyo
20
Discovery of novel PTHR1 antagonists: Design, synthesis, and structure activity relationships.
Daiichi Sankyo
6
New Modalities, Technologies, and Partnerships in Probe and Lead Generation: Enabling a Mode-of-Action Centric Paradigm.
AstraZeneca
87
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design.
Bristol Myers Squibb
12
Lead Optimization and Avoidance of Reactive Metabolite Leading to PCO371, a Potent, Selective, and Orally Available Human Parathyroid Hormone Receptor 1 (hPTHR1) Agonist.
Chugai Pharmaceutical
8
Development of a Novel Human Parathyroid Hormone Receptor 1 (hPTHR1) Agonist (CH5447240), a Potent and Orally Available Small Molecule for Treatment of Hypoparathyroidism.
Chugai Pharmaceutical
41
Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with BroadĪ² Residue Distribution.
University of Wisconsin-Madison
